NextPlat NXPL
NASDAQ NXPL
$9.13 -0.30 (-3.18%)
At close: Sep 4, 2026 · 4:00 PM EDT

NextPlat (NXPL) Notes Payables (2012 - 2026)

NextPlat's (NXPL) quarterly Notes Payables came in at $189000.0 in Q2 2026, down 11.27% year-over-year from $213000.0 in Q2 2025, and down 38.03% quarter-over-quarter from $305000.0 in Q1 2026.

Analysis

NextPlat (NXPL) Notes Payables (2012 - 2026) Analysis & Trends

NextPlat (NXPL) has reported Notes Payables for 15 consecutive years, with $189000.0 the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Notes Payables fell 11.27% year-over-year to $189000.0 in Q2 2026; TTM through Jun 2026 was $189000.0, a 11.27% decrease from a year earlier, with the FY2025 full-year figure at $416000.0, up 9.47% from the prior year.
  • Notes Payables was $189000.0 for Q2 2026 at NextPlat, down from $305000.0 in the prior quarter.
  • Over five years, Notes Payables peaked at $461000.0 in Q3 2024 and troughed at $55045.0 in Q1 2022.
  • A 5-year average of $222940.8 and a median of $223000.0 in 2024 frame the typical range for Notes Payables.
  • Across the five-year window, Notes Payables plunged 71.98% in 2022 and jumped 591.13% in 2023, its largest moves.
  • Over 5 years, Notes Payables stood at $60000.0 in 2022, then jumped by 420.0% to $312000.0 in 2023, then climbed by 21.79% to $380000.0 in 2024, then advanced by 9.47% to $416000.0 in 2025, then slumped by 54.57% to $189000.0 in 2026.
  • The last three Notes Payables figures came in at $189000.0 (Q2 2026), $305000.0 (Q1 2026), and $416000.0 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 42.34 Bn 38.68 Bn 2.15 Bn
2 Viatris 19.39 Bn 18.50 Bn 1.46 Bn
3 Dr Reddys Laboratories 9.99 Bn 9.85 Bn 396.53 Mn
4 Amneal Pharmaceuticals 5.57 Bn 5.53 Bn 334.51 Mn
5 Bausch Health Companies 2.45 Bn 1.58 Bn 2.10 Bn
6 Ani Pharmaceuticals 1.70 Bn 1.34 Bn 165.89 Mn
7 Alvotech 1.66 Bn 1.52 Bn 2.56 Mn
8 Amphastar Pharmaceuticals 985.90 Mn 695.77 Mn 93.47 Mn
9 Fennec Pharmaceuticals 434.07 Mn 392.82 Mn 17.15 Mn
10 NextPlat 24.77 Mn 12.93 Mn 4.69 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 189,000.00
Mar 31, 2026 305,000.00
Dec 31, 2025 416,000.00
Sep 30, 2025 252,000.00
Jun 30, 2025 213,000.00
Mar 31, 2025 305,000.00
Dec 31, 2024 380,000.00
Sep 30, 2024 461,000.00
Jun 30, 2024 205,000.00
Mar 31, 2024 233,000.00
Dec 31, 2023 312,000.00
Sep 30, 2023 385,303.00
Jun 30, 2023 63,171.00
Mar 31, 2023 61,840.00
Dec 31, 2022 60,000.00
Sep 30, 2022 55,750.00
Jun 30, 2022 60,825.00
Mar 31, 2022 55,045.00
Dec 31, 2021 56,391.00
Sep 30, 2021 67,273.00